Simvastatin for patients with acute respiratory distress syndrome: long-term outcomes and cost-effectiveness from a randomised controlled trial. (2017)
Attributed to:
Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunctio
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13054-017-1695-0
PubMed Identifier: 28511660
Publication URI: http://europepmc.org/abstract/MED/28511660
Type: Journal Article/Review
Volume: 21
Parent Publication: Critical care (London, England)
Issue: 1
ISSN: 1364-8535